LVCLF
Price:
$0.00425
Market Cap:
$11.03M
Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Sydney, Australia.[Read more]
Industry
Biotechnology
IPO Date
2010-06-01
Stock Exchange
PNK
Ticker
LVCLF
According to Living Cell Technologies Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 7.92M. This represents a change of -45.65% compared to the average of 14.57M of the last 4 quarters.
The mean historical Enterprise Value of Living Cell Technologies Limited over the last ten years is 15.70M. The current 7.92M Enterprise Value has changed 4.94% with respect to the historical average. Over the past ten years (40 quarters), LVCLF's Enterprise Value was at its highest in in the September 2017 quarter at 98.96M. The Enterprise Value was at its lowest in in the December 2021 quarter at -654856.51.
Average
15.70M
Median
13.01M
Minimum
4.75M
Maximum
51.86M
Discovering the peaks and valleys of Living Cell Technologies Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 204.94%
Maximum Annual Enterprise Value = 51.86M
Minimum Annual Increase = -82.50%
Minimum Annual Enterprise Value = 4.75M
Year | Enterprise Value | Change |
---|---|---|
2024 | 13.56M | -6.42% |
2023 | 14.49M | 204.94% |
2022 | 4.75M | -16.58% |
2021 | 5.69M | 9.87% |
2020 | 5.18M | -58.45% |
2019 | 12.47M | 37.40% |
2018 | 9.08M | -82.50% |
2017 | 51.86M | 156.91% |
2016 | 20.19M | 2.09% |
2015 | 19.78M | 1.38% |
The current Enterprise Value of Living Cell Technologies Limited (LVCLF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
10.93M
5-year avg
8.73M
10-year avg
15.70M
Living Cell Technologies Limited’s Enterprise Value is
Company | Enterprise Value | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Living Cell Technologies Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Living Cell Technologies Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Living Cell Technologies Limited's Enterprise Value?
What is the highest Enterprise Value for Living Cell Technologies Limited (LVCLF)?
What is the 3-year average Enterprise Value for Living Cell Technologies Limited (LVCLF)?
What is the 5-year average Enterprise Value for Living Cell Technologies Limited (LVCLF)?
How does the current Enterprise Value for Living Cell Technologies Limited (LVCLF) compare to its historical average?